MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Leukotriene receptor antagonists

Drug Safety Update

 April 2024: Montelukast: reminder of the risk of neuropsychiatric reactions

 September 2019: Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions

NICE Guidance

  NG80: Asthma diagnosis, monitoring and chronic asthma management, November 2017 (updated March 2021)

  BTS/SIGN British Guideline on the management of asthma, July 2019

Local Guidance

See here for available local respiratory system guidance

Leukotriene receptor antagonists may be of benefit in exercise induced asthma and in those with concomitant rhinitis

Acute asthma: these agents should not be used to relieve an acute asthma attack and their use does not necessarily allow a reduction in existing corticosteroid treatment

Pack Price
28 tablet £1.41
30 tablet
Pack Price
28 tablet £0.97
30 tablet
Pack Price
28 tablet £1.10
30 tablet